Nextcure, Inc.
Clinical trials sponsored by Nextcure, Inc., explained in plain language.
-
New drug LNCB74 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called LNCB74 in people with advanced solid tumors (cancers that have spread and are hard to treat). The drug is designed to attach to a protein on cancer cells and deliver a toxic payload to kill them. The main goals are to find a safe dos…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC
-
New hope for advanced tumors? first human trial of SIM0505 begins
Disease control Recruiting nowThis early-stage study tests a new drug, SIM0505, in adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the right dose, and see if the drug can shrink tumors. About 414 people will take part across multiple c…
Phase: PHASE1 • Sponsor: NextCure, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC